Generic drug maker Granules India has been criticized by the FDA after inspectors found three trucks full of torn-up ...

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...

Edgewise Therapeutics has unveiled early safety data for its rare heart disease drug, with results suggesting it could do ...

D Molecular Therapeutics' one-time gene therapy reduced the need for annual injections in patients with age-related blindness ...

Progyny lost a big client that made up around 670,000 members, the fertility benefits company said in a securities filing ...

Valo Health, the well-funded computational drug discovery and development startup launched by Flagship Pioneering, lost its ...

A startup that uses AI to provide insights from unstructured health data just raised a seed round, with plans to start ...

The FDA flashed a red light on Vanda Pharmaceuticals' experimental treatment for a gastrointestinal condition that disrupts ...

Plus, news about GSK, Novo Nordisk, Tanai Therapeutics, Nomic Bio, Brenus Pharma, Xspray, Achilles Therapeutics, BioXcel Therapeutics and Nuvalent: Ascendis’ $300M offering: The Danish company ...

A few months after a key label expansion, AstraZeneca’s asthma treatment Fasenra has received FDA approval to treat a rare ...

GC Ther­a­peu­tics, a biotech start­up that is writ­ing the recipe book for turn­ing a stem cell in­to near­ly any nat­ur­al ...

Keytruda is already approved in more than 40 different oncology indications, but its latest label expansion is a first for ...